Literature DB >> 21447829

Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes.

Akira Umino1, Masao Nakagawa, Atae Utsunomiya, Kunihiro Tsukasaki, Naoya Taira, Naoyuki Katayama, Masao Seto.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is the neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1). We performed oligo-array comparative genomic hybridization (CGH) against paired samples comprising peripheral blood (PB) and lymph node (LN) samples from 13 patients with acute ATLL. We found that the genome profiles of the PB frequently differed from those of the LN samples. The results showed that 9 of 13 cases investigated had a log2 ratio imbalance among chromosomes, and that chromosome imbalances were more frequent in LN samples. Detailed analysis revealed that the imbalances were likely caused by the presence of multiple subclones in the LN samples. Five of 13 cases showed homozygous loss regions in PB samples, which were not found in the LN samples, indicating that tumors in the PB were derived from LN subclones in most cases. Southern blot analysis of TCRγ showed that these multiple subclones originated from a common clone. We concluded that in many ATLL cases, multiple subclones in the LNs originate from a common clone, and that a selected subclone among the LN subclones appears in the PB.

Entities:  

Mesh:

Year:  2011        PMID: 21447829     DOI: 10.1182/blood-2010-12-327791

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.

Authors:  Madeleine Duvic; Lauren C Pinter-Brown; Francine M Foss; Lubomir Sokol; Jeffrey L Jorgensen; Pramoda Challagundla; Karen M Dwyer; Xiaoping Zhang; Michael R Kurman; Rocco Ballerini; Li Liu; Youn H Kim
Journal:  Blood       Date:  2015-01-20       Impact factor: 22.113

2.  Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Authors:  Satoshi Morishige; Marina Nishi; Hiroshi Saruta; Fumiko Arakawa; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Ritsuko Seki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koichi Osaki; Koichi Ohshima; Koji Nagafuji
Journal:  Int J Hematol       Date:  2019-05-31       Impact factor: 2.490

3.  Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor.

Authors:  P Brunner; A Rufle; S Dirnhofer; A Lohri; N Willi; G Cathomas; A Tzankov; D Juskevicius
Journal:  Leukemia       Date:  2014-05-21       Impact factor: 11.528

Review 4.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

Review 5.  Human T-cell lymphotropic virus type 1 and its oncogenesis.

Authors:  Lan-Lan Zhang; Jing-Yun Wei; Long Wang; Shi-le Huang; Ji-Long Chen
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

6.  The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.

Authors:  Haitao Zheng; Xu Wang; Yu Ma; Bing Xu; Shaohua Chen; Lijian Yang; Xiuli Wu; Grzegorz K Przybylski; Suming Huang; Tiezhen Ye; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2013-12-13       Impact factor: 3.311

Review 7.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464

8.  Transmission of Human T-Lymphotropic Virus Type I to Donor-Origin T Cells During Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Makoto Hirosawa; Daisuke Niino; Junichi Tsukada
Journal:  J Hematol       Date:  2022-03-12

Review 9.  Recent advances in the treatment of adult T-cell leukemia-lymphomas.

Authors:  Atae Utsunomiya; Ilseung Choi; Dai Chihara; Masao Seto
Journal:  Cancer Sci       Date:  2015-03-06       Impact factor: 6.716

10.  Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations.

Authors:  Noriaki Yoshida; Akira Umino; Fang Liu; Kotaro Arita; Kennosuke Karube; Shinobu Tsuzuki; Koichi Ohshima; Masao Seto
Journal:  Cancer Med       Date:  2012-09-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.